| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 03/31/2005 | US20050070494 Transforming growth factor-beta response element decoys and methods |
| 03/31/2005 | US20050070493 Methods and compositions for treating Parkinson's disease |
| 03/31/2005 | US20050070492 Use of a ribozyme for inhibiting gene expression; screening for oligonucleotide antisense agents |
| 03/31/2005 | US20050070491 Immunostimulatory nucleic acid molecules |
| 03/31/2005 | US20050070490 Selected from an antisense oligonucleotide, a ribozyme, a protein, a polypeptide, an antibody, and a small molecule; guanine nucleotide exchange factor Sos1 which couples receptor tyrosine kinases (RTKs) to ras activation; inhibition to treat cancer |
| 03/31/2005 | US20050070474 Methods of treatment and compositions therefor |
| 03/31/2005 | US20050070463 membrane proteins associated with LPSs (lipopolysaccharides), for inducing maturation of dendritic cells; membrane fraction has a proteoglycan titer, represented by the sum of the contents of galactose and of proteins, between 1.2 g/l - 3.4 g/l for galactose and between 7.5 g/l - 14.9 g/l for proteins |
| 03/31/2005 | US20050070462 Contacting with cationic polymer |
| 03/31/2005 | US20050070435 encoding indole-3 acetic acid (IAA) production; Acinetobacter strains having the plasmid; a bioinoculum for promoting growth of wheat plant |
| 03/31/2005 | US20050070018 Device which utilizes spatially variant voltages to make subsets of cultured cells or lipid vesicles porous; transferring nucleic acids through membranes; RNA interference |
| 03/31/2005 | US20050070017 Adenoviral vaccine composition for use in prevention and treatment of viral infection; viricides; veterinary medicine |
| 03/31/2005 | US20050070016 Which mimic activation domains; fusion proteins; binding proteins |
| 03/31/2005 | US20050070015 Methods of controlling proliferation of cancer cells and cell death |
| 03/31/2005 | US20050070014 Method of expressing foreign gene in kidney |
| 03/31/2005 | US20050070007 Methods and compositions for highly efficient transformation of filamentous fungi |
| 03/31/2005 | US20050070005 High throughput or capillary-based screening for a bioactivity or biomolecule |
| 03/31/2005 | US20050070003 Glucanase enzyme mixture for use in textile treatment and laundering detergents |
| 03/31/2005 | US20050070002 Histidine phosphatase interacting protein with 120kd |
| 03/31/2005 | US20050069995 (R)-hydroxycarboxylic acid producing recombinant microorganism and process for preparing (r)-hydroxycarboxylic acid using the same |
| 03/31/2005 | US20050069994 Nitrate reductase (NIR) defective escherichia for use in biosynthesis of arginine; bioreactors; supplements for medicine, animal feeds and cosmetics |
| 03/31/2005 | US20050069993 Fermentation, concentration; gene overexpression by increasing copy number or operably linking to promoter; quantitative analysis; isolation of L-threonine or L-lysine |
| 03/31/2005 | US20050069991 Preparing plasmids comprising providing solution of unligatable open circular plasmids, react unligatable open DNA with enzymes and generating 3'-hydroxyl, 5'-phosphate nicked plasmid, react with ligase generating relaxed closed plasmid, react with gyrase and recover supercoiled plasmid |
| 03/31/2005 | US20050069990 R2D2: an enzyme of RNA silencing |
| 03/31/2005 | US20050069988 Recombinant expression systems for production of low solubility foreign proteins specifically aminoglobulin |
| 03/31/2005 | US20050069987 Engineered nerve growth factor for use as tool in prevention and treatment of obesity |
| 03/31/2005 | US20050069986 Nucleotide sequences coding histonw actyltransferase inhibitor for use as tool in treatment and prevention of cell proliferative disorders; immunotherapy; gene expression inhibition |
| 03/31/2005 | US20050069984 Identification of sortase gene |
| 03/31/2005 | US20050069983 Nucleotide sequences coding membrane protein for use in identifying modulator for prevention and treatment of herpes viral infection, cell proliferative and autoimmune disorders |
| 03/31/2005 | US20050069981 Human vascular IBP-like growth factor |
| 03/31/2005 | US20050069980 Transport protein for use as tool in altering in vivo pharmacokinetics of a pharmaceutical, toxic substance or xenobiotics by modulating an ability to transport acidic amino acids; antitumor agents |
| 03/31/2005 | US20050069979 Cell culture process |
| 03/31/2005 | US20050069977 Antimicrobial proteins, genes encoding the proteins and method of using the same |
| 03/31/2005 | US20050069968 Sampling cerebrospinal fluid for antibodies; solid phase synthesis; immunoassay |
| 03/31/2005 | US20050069960 Which induce proliferation of tumor-infiltrating lymphocytes without systemic toxicity associated with the administration of wild-type cytokines; drug screening/design |
| 03/31/2005 | US20050069948 Using suppressor of early growth response-1 (Egr-1) protein as tool in treatment of kidney disorders |
| 03/31/2005 | US20050069946 Expression analysis of FKBP54 in the diagnosis and treatment of prostate cancer |
| 03/31/2005 | US20050069944 Nucleotide sequences coding G-protein coupled receptor for use in identifying modulator of tase transduction; flavoring and food processing |
| 03/31/2005 | US20050069943 101 human secreted proteins |
| 03/31/2005 | US20050069942 Vaccine vector comprising isolated nucleic acid molecule which encodes sequence 2 linked to promoter |
| 03/31/2005 | US20050069939 Replicating polynucleotides, comprising: forming linear polynuclelotides having 3' and 5' hairpins, ligating 3' and 5' ends of the linear target to form a circularized polynucleotide, amplify circularized polynucleotide and recover product |
| 03/31/2005 | US20050069938 Amplification of polynucleotides by rolling circle amplification |
| 03/31/2005 | US20050069937 Spotting method onto and data reading method from biochemical analysis unit |
| 03/31/2005 | US20050069933 Transcritional replication enzyne for use in synthesizing RNA strands complementary to an RNA template; creating CDNA libraries |
| 03/31/2005 | US20050069931 Non-invasive diagnostic test utilizing histone modification markers |
| 03/31/2005 | US20050069930 Ring finger protein 43 for use as diagnostic indicator of cell proliferative disorders; antitumor agents; RNA interference; drug screening |
| 03/31/2005 | US20050069929 Methods and compositions for seamless cloning of nucleic acid molecules |
| 03/31/2005 | US20050069928 Methods for synthesis of defined polynucleotides |
| 03/31/2005 | US20050069924 Differentially methylated sequences in pancreatic cancer |
| 03/31/2005 | US20050069922 Using presence of short expansion sequences in poly(A) binding protein II (PAB II) gene as diagnostic indicator of disease associated with polyalanine and protein accumulation in nucleus |
| 03/31/2005 | US20050069921 Compositions, kits, and methods for stimulation of homologous recombination |
| 03/31/2005 | US20050069920 Using encapuslated gene sequences as tools for directed evolution of nucleic acids; microencapsulation and gene expression |
| 03/31/2005 | US20050069919 Novel human secreted proteins and polynucleotides encoding the same |
| 03/31/2005 | US20050069917 High throughput screening for novel enzymes |
| 03/31/2005 | US20050069910 Nucleic acid ligands to complex targets |
| 03/31/2005 | US20050069909 Method to identify and analyze genes having modified expression in activated cells with secretory lysosomes |
| 03/31/2005 | US20050069908 DNA polymerase compositions for quantitative PCR and methods thereof |
| 03/31/2005 | US20050069896 Rb pathway and chromatin remodeling genes that antagonize let-60 Ras signaling |
| 03/31/2005 | US20050069894 Identification of new small RNAs and ORFs of E. coli as mediators of cell and intercell regulation |
| 03/31/2005 | US20050069893 Diagnostic method for glaucoma |
| 03/31/2005 | US20050069891 Method of specifying snp |
| 03/31/2005 | US20050069890 Method for the detection and/or identification of the original animal species in animal matter contained in a sample |
| 03/31/2005 | US20050069888 Common lymphatic endothelial and vascular endothelial receptor-1 (clever-1) and uses thereof |
| 03/31/2005 | US20050069885 Transformed yeast comprising defective urea carboxylase-allophanate hydrolase gene and reduce nitrogen catabolite repression for use as tool in fermentation of alcoholic beverages |
| 03/31/2005 | US20050069884 Manipulation of flavonoid biosynthesis in plants |
| 03/31/2005 | US20050069883 Melanin-concentrating hormone receptor antagonist binding protein |
| 03/31/2005 | US20050069878 Proteins associated with cell growth, differentiation, and death |
| 03/31/2005 | US20050069877 Protein modification and maintenance polypeptides (PMOD) for use as diagnostic and therapeutic tools in treatment of prevention of gastrointestinal, cardiovascular, autoimmune/inflammatory, cell proliferative, developmental, epithelial, neurological, and reproductive disorders |
| 03/31/2005 | US20050069876 Polypeptide for use in diagnosis, treatment and prevention of cell proliferative, autoimmune, inflammatory, cardiovascular, neurological and developmental disorders. |
| 03/31/2005 | US20050069873 Nucleotide sequences coding insulin like growth factor binding protein-3 (IGFBP-3) receptor for use as tool in diagnosis, prevention and treatment of cell proliferative disorders |
| 03/31/2005 | US20050069872 Mutated aqp, method for detecting cancer using the same, dna chip having oligonucleotides of said mutated aqp sequence |
| 03/31/2005 | US20050069871 Polypeptide-human zinc finger protein fpm315-17 and the polynucleotide encoding it |
| 03/31/2005 | US20050069866 Simian adenovirus nucleic acid and amino acid sequences, vectors containing same, and methods of use |
| 03/31/2005 | US20050069865 Synthetic hcv envelope proteins and their use for vaccination |
| 03/31/2005 | US20050069577 Synthesis and use of reagents for improved DNA lipofection and/or slow release prodrug and drug therapies |
| 03/31/2005 | US20050069569 Osteocalcin; enzyme inhibitors; promote bone, teeth growth; administering Dna gene |
| 03/31/2005 | US20050069559 Lawsonia intracellularis vaccine |
| 03/31/2005 | US20050069557 A protein neuroglobin derived from neuronal tissue; binging, storage oxygen; therapy for central nervous system disorders |
| 03/31/2005 | US20050069556 Serology display library; analyzing autologous tumor antigen; drug design; antitumor vaccine containing antigen |
| 03/31/2005 | US20050069547 Binding protein; therapy for bone tumors |
| 03/31/2005 | US20050069535 Immunotherapeutic combinations for the treatment of tumours that overexpress gangliosides |
| 03/31/2005 | US20050069524 Methods for insertion of nucleic acids into circular vectors |
| 03/31/2005 | US20050069523 Recombinant adenoviruses encoding glial cell neurotrophic factor (GDNF) |
| 03/31/2005 | US20050069491 Dna sequences encoding detectable cytotoxic protein generating signal; tumor imaging; gene expression |
| 03/31/2005 | DE10341272A1 Preparing genetically modified Blakeslea, useful for preparation of carotenoids, useful as food additives, cosmetics or pharmaceuticals, comprises transformation, optional homokaryotizing, and selection |
| 03/31/2005 | DE10341271A1 Preparing carotenoids or their precursors useful e.g. in cosmetics, pharmaceuticals, foods and animal feeds, comprises culturing genetically modified Blakeslea |
| 03/31/2005 | CA2818763A1 Methods, compositions, and kits for the concentration and detection of microorganisms |
| 03/31/2005 | CA2770976A1 Cbh1 homologs and variant cbh1 cellulases |
| 03/31/2005 | CA2579638A1 Rna interference targeting non-disease causing single nucleotide polymorphisms within a gene encoding a gain-of-function mutant huntingtin protein |
| 03/31/2005 | CA2540180A1 Banana resistance genes and uses thereof |
| 03/31/2005 | CA2540155A1 Excretable reporter systems |
| 03/31/2005 | CA2540138A1 Recombinant antibody against human insulin-like growth factor |
| 03/31/2005 | CA2540103A1 Selective inhibition of nf-kappab activation by peptides designed to disrupt nemo oligomerization |
| 03/31/2005 | CA2539789A1 Peptide originating in hepatitis c virus |
| 03/31/2005 | CA2539457A1 Nucleic acid and gene derived from novel hcv strain and replicon-replicating cell using said gene |
| 03/31/2005 | CA2539325A1 Consensus/ancestral immunogens |
| 03/31/2005 | CA2539322A1 Kid3 and kid3 antibodies that bind thereto |
| 03/31/2005 | CA2539181A1 Modulation of eif4e expression |
| 03/31/2005 | CA2539131A1 Diagnostic system for otolaryngologic pathogens and use thereof |
| 03/31/2005 | CA2539127A1 Receptor |
| 03/31/2005 | CA2539074A1 Campylobacter polypeptides and methods of use |